Co-Diagnostics (CODX) Reports In-Line Q1 EPS, Revenues Beat

Go back to Co-Diagnostics (CODX) Reports In-Line Q1 EPS, Revenues Beat

Co-Diagnostics (CODX) IV at 279 on wide price movement

May 14, 2020 2:44 PM EDT

Co-Diagnostics (NASDAQ: CODX) 30-day option implied volatility is at 279; compared to its 52-week range of 170 to 448.

... More

Co-Diagnostics (CODX) Halted on Circuit Breaker

May 14, 2020 1:50 PM EDT

Co-Diagnostics (NASDAQ: CODX) halted on a circuit breaker following negative report and a short report. Shares last down 8.8%.

... More

UPDATE: Hindenburg Research short Co-Diagnostics (CODX); Sees Shares Back to 'Single Digits'

May 14, 2020 1:39 PM EDT

(Updated - May 14, 2020 1:42 PM EDT)

Hindenburg Research short Co-Diagnostics (NASDAQ: CODX), saying they see shares back to 'single digits in short order'.

We are short... More

UPDATE: Co-Diagnostics (CODX) lower on negative report

May 14, 2020 1:26 PM EDT

(Updated - May 14, 2020 1:31 PM EDT)

Co-Diagnostics (NASDAQ: CODX) lower on negative report.

UPDATE: The downside is related to news several Nebraska state senators want to terminate $27 million in no-bid contracts awarded to several Utah-based tech companies to do data collection and coronavirus testing. (LINK)

... More